CrushSCI.com
Journal Selection & Manuscript Polishing Services
DRUG METABOLISM REVIEWS journal cover Medicine
Back to journal directory

Review Cycle Records

DRUG METABOLISM REVIEWS

Taylor & Francis SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 32025 JCR Q2
90.4Average days
83Median days
26Fastest days
178Longest days
232025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

144 days

Bioactivation and reactivity research advances – 2025 year in review

AuthorsJoyce Liu; Upendra A. Argikar; Pietro Brunetti; Maria Chatzopoulou; Sungjoon Cho; Alf Claesson; Deepika Dhaware; Jakob Lang; Bin Ma; Shuguang Ma; Hlaing Maw; Grover P. Miller; Simone Schadt; Herana Kamal Seneviratne; Lloyd Wei Tat Tang; Caroline Wei; S. Cyrus Khojasteh

Affiliations1. Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc; 2. Non-clinical Development, Gates Medical Research Institute; 3. Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd; 4. UCB; 5. Awametox AB; 6. DMPK and Safety Sciences, Orion Pharma; 7. Department of Drug Metabolism and Pharmacokinetics, Gilead Sciences, Inc; 8. Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc; 9. Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences; 10. Department of Chemistry and Biochemistry, University of Maryland, Baltimore County; 11. Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc; 12. Quantitative Clinical Pharmacology, Daiichi Sankyo Inc

Source PDF DOI Publisher page
43 days

Drug transporters in drug disposition – highlights from the year 2025

AuthorsPhilip Sandoval; Pallabi Mitra; Masanori Nakakariya; Diane Ramsden; Charles J. Rotter; Ning Ding; Paresh P. Chothe

Affiliations1. Takeda Development Center Americas, Inc. (TDCA); 2. Department of Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals Inc.; 3. Takeda Pharmaceutical Company Limited; 4. Preclinical Development, Korro Bio, Inc.; 5. Rapport Therapeutics; 6. Drug Metabolism and Pharmacokinetics, Oncology Research and Development, AstraZeneca

Source PDF DOI Publisher page
178 days

Herbal supplements and anti-tuberculosis therapy: unlocking hidden interactions for better multidrug-resistant tuberculosis management

AuthorsSiva Bhukya; Ravi Adinarayan Somabattini; Neelanjan Chowdhury; Sathi Sarkar; Anish Kumar Das; Kabita Mahato; Hanumu Korra; Satheesh Kumar Nanjappan

Affiliations1. Department of Natural Products, National Institute of Pharmaceutical Education and Research (NIPER) Kolkata

Source PDF DOI Publisher page
57 days

Biotransformation research advances—2025 year in review

AuthorsLionel Cheruzel; Upendra A. Argikar; Pietro Brunetti; Maria Chatzopoulou; Luying Chen; Sungjoon Cho; Deepika Dhaware; Carley J. S. Heck; Chandrashekhar Honrao; S. Cyrus Khojasteh; Jed N. Lampe; Jakob Lang; Bin Ma; Shuguang Ma; Karoline Rehm; Jessica A. Rowley; Herana Kamal Seneviratne; Hyeonglim Seo; Lloyd Wei Tat Tang; Yue-Ting Wang; Caroline Wei

Affiliations1. Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc.; 2. Non-clinical Development, Gates Medical Research Institute; 3. Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd; 4. UCB; 5. Department of Pharmaceutical Sciences, China Innovation Center of Roche; 6. DMPK and Safety Sciences, Orion Pharma; 7. Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc.; 8. Pharmacokinetics, Dynamics, Metabolism, and Bioanalytics, Merck & Co., Inc.; 9. Department of Pharmaceutical Sciences, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; 10. Department of Drug Metabolism and Pharmacokinetics, Gilead Sciences, Inc.; 11. Department of Chemistry and Biochemistry, University of Maryland; 12. Quantitative, Translational & ADME Sciences (QTAS), AbbVie; 13. Quantitative Clinical Pharmacology, Daiichi Sankyo Inc.

Source PDF DOI Publisher page
87 days

Pharmacomicrobiomics in precision pharmacotherapy: bidirectional microbial-drug interactions as a key determinant of therapeutic response

AuthorsSerap Yalçın Azarkan; Habibe Sema Arslan Ünal; Sevinç Akçay

Affiliations1. Department of Medical Pharmacology, Faculty of Medicine, Kırşehir Ahi Evran University; 2. Department of Medical Genetics, Faculty of Medicine, Kırşehir Ahi Evran University; 3. Department of Molecular Biology and Genetics, Faculty of Science and Art, Kırşehir Ahi Evran University

Source PDF DOI Publisher page
140 days

Population pharmacokinetics of levofloxacin: a systematic review

AuthorsYifan Ding; Xianghai Zeng; Jing Zou; Yuxue Zhou; Jiali Zhang; Zhao Chang; Shengnan Zhang; Meng Lv

Affiliations1. Department of Pharmacy, Children’s Hospital Affiliated to Zhengzhou University

Source PDF DOI Publisher page
56 days

Metabolism of new drug modalities research advances – 2025 year in review

AuthorsBin Ma; Lionel Cheruzel; Sungjoon Cho; Simon Hauri; Xiuli Li; Joyce Liu; Karoline Rehm; Herana Kamal Seneviratne; Hyeonglim Seo; Rachel Liuqing Shi; Lloyd Wei Tat Tang; Pengcheng Wang; Yue-Ting Wang; Caroline Wei; Guo Zhong; S. Cyrus Khojasteh

Affiliations1. Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc; 2. Roche Pharma Research and Early Development, Pharmaceutical Sciences; 3. Department of Pharmaceutical Sciences, China Innovation Center of Roche; 4. Department of Chemistry and Biochemistry, University of Maryland; 5. Department of Biochemical and Cellular Pharmacology, Genentech, Inc; 6. Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc; 7. Pharmacokinetic Sciences Biomedical Research; 8. Quantitative, Translational, & ADME Sciences (QTAS), AbbVie Inc; 9. Quantitative Clinical Pharmacology, Daiichi Sankyo Inc; 10. Pharmacokinetics and Drug Metabolism Department

Source PDF DOI Publisher page
79 days

Extracellular vesicles as xenobiotic-metabolizing enzyme carriers: a new paradigm for brain drug metabolism

AuthorsVeena V Tom; Ann Mary Jose; Athira Sasidharan; Yogish Somayaji; Ronald Fernandes

Affiliations1. Department of Allied Health Sciences, Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS); 2. Department of Post Graduate Studies and Research in Biochemistry, St. Aloysius (Deemed to be University); 3. Department of Biochemistry and Biophysics, Texas A&M University; 4. Department of Pharmaceutical Chemistry, Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS)

Source PDF DOI Publisher page
26 days

Cytochrome P450-derived arachidonic acid metabolites as emerging therapeutic targets in menopause-associated cardiac hypertrophy

AuthorsMostafa K. Abd El-Aziz; Ali H. Shalaby; Sara R. El-Mahrouk; Ayman O. S. El-Kadi

Affiliations1. Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta

Source PDF DOI Publisher page
83 days

Exploring the clinical pharmacokinetics and pharmacodynamics of SGLT2 inhibitor, empagliflozin: a systematic review

AuthorsTahir Saleem; Muhammad Fawad Rasool; Hamid Saeed; Faleh Alqahtani

Affiliations1. Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University; 2. University College of Pharmacy, Allama Iqbal Campus, University of the Punjab; 3. Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.